Anika Therapeutics, Inc. Revenue, Net (Deprecated 2018-01-31)
Anika Therapeutics, Inc. (ANIK) reported Revenue, Net (Deprecated 2018-01-31) of $29.39 million for the 3-month period ending 2017-12-31, per its 10-K filed 2018-02-27.
Discontinued › Income Statement › Revenue
us-gaap:SalesRevenueNet · last filed 2018-02-27
- Anika Therapeutics, Inc. revenue, net (deprecated 2018-01-31) for the quarter ending 2017-12-31 was $29.39M, a 2.30% increase year-over-year.
- Anika Therapeutics, Inc. revenue, net (deprecated 2018-01-31) for the quarter ending 2017-09-30 was $27.18M, a 5.41% increase year-over-year.
- Anika Therapeutics, Inc. revenue, net (deprecated 2018-01-31) for the quarter ending 2017-06-30 was $33.46M, a 25.89% increase year-over-year.
- Anika Therapeutics, Inc. revenue, net (deprecated 2018-01-31) for the quarter ending 2017-03-31 was $23.39M, a 4.95% increase year-over-year.
- Anika Therapeutics, Inc. revenue, net (deprecated 2018-01-31) for fiscal 2017 was $113.42M, a 9.71% increase from fiscal 2016.
- Anika Therapeutics, Inc. revenue, net (deprecated 2018-01-31) for fiscal 2016 was $103.38M, a 11.16% increase from fiscal 2015.
- Anika Therapeutics, Inc. revenue, net (deprecated 2018-01-31) for fiscal 2015 was $93.00M, a 11.93% decline from fiscal 2014.
- Anika Therapeutics, Inc. revenue, net (deprecated 2018-01-31) for fiscal 2014 was $105.59M, a 40.64% increase from fiscal 2013.
| Period end | Revenue, Net (Deprecated 2018-01-31) 3 month | Revenue, Net (Deprecated 2018-01-31) 3 month as first filed | Revenue, Net (Deprecated 2018-01-31) 6 month | Revenue, Net (Deprecated 2018-01-31) 6 month as first filed | Revenue, Net (Deprecated 2018-01-31) 9 month | Revenue, Net (Deprecated 2018-01-31) 9 month as first filed | Revenue, Net (Deprecated 2018-01-31) 12 month | Revenue, Net (Deprecated 2018-01-31) 12 month as first filed |
|---|---|---|---|---|---|---|---|---|
| 2017-12-31 | $29.39M 10-K · filed 2018-02-27 | $56.57M derived: sum of 2 quarters · filed 2018-02-27 | $90.03M derived: sum of 3 quarters · filed 2018-02-27 | $113.42M 10-K · filed 2018-02-27 | ||||
| 2017-09-30 | $27.18M 10-K · filed 2018-02-27 | $60.65M derived: sum of 2 quarters · filed 2018-02-27 | $84.03M 10-Q · filed 2017-10-27 | $112.76M derived: sum of 4 quarters · filed 2018-02-27 | ||||
| 2017-06-30 | $33.46M 10-K · filed 2018-02-27 | $56.85M 10-Q · filed 2017-07-28 | $85.57M derived: sum of 3 quarters · filed 2018-02-27 | $111.36M derived: sum of 4 quarters · filed 2018-02-27 | ||||
| 2017-03-31 | $23.39M 10-K · filed 2018-02-27 | $52.11M derived: sum of 2 quarters · filed 2018-02-27 | $77.90M derived: sum of 3 quarters · filed 2018-02-27 | $104.48M derived: sum of 4 quarters · filed 2018-02-27 | ||||
| 2016-12-31 | $28.73M 10-K · filed 2018-02-27 | $54.52M derived: sum of 2 quarters · filed 2018-02-27 | $81.10M derived: sum of 3 quarters · filed 2018-02-27 | $103.38M 10-K · filed 2018-02-27 | ||||
| 2016-09-30 | $25.79M 10-K · filed 2018-02-27 | $52.37M derived: sum of 2 quarters · filed 2018-02-27 | $74.65M 10-Q · filed 2017-10-27 | $105.55M derived: sum of 4 quarters · filed 2018-02-27 | ||||
| 2016-06-30 | $26.58M 10-K · filed 2018-02-27 | $48.86M 10-Q · filed 2017-07-28 | $79.76M derived: sum of 3 quarters · filed 2018-02-27 | $103.44M derived: sum of 4 quarters · filed 2018-02-27 | ||||
| 2016-03-31 | $22.28M 10-K · filed 2018-02-27 | $53.18M derived: sum of 2 quarters · filed 2018-02-27 | $76.86M derived: sum of 3 quarters · filed 2018-02-27 | $99.76M derived: sum of 4 quarters · filed 2018-02-27 | ||||
| 2015-12-31 | $30.89M 10-K · filed 2017-02-24 | $54.58M derived: sum of 2 quarters · filed 2017-02-24 | $77.48M derived: sum of 3 quarters · filed 2017-02-24 | $93.00M 10-K · filed 2018-02-27 | ||||
| 2015-09-30 | $23.68M 10-K · filed 2017-02-24 | $23.68M 10-Q · filed 2015-11-03 | $46.59M derived: sum of 2 quarters · filed 2017-02-24 | $62.10M 10-Q · filed 2016-11-01 | $62.11M 10-Q · filed 2015-11-03 | $85.36M derived: sum of 4 quarters · filed 2017-02-24 | ||
| 2015-06-30 | $22.90M 10-K · filed 2017-02-24 | $22.90M 10-Q · filed 2015-08-04 | $38.42M 10-Q · filed 2016-08-01 | $38.42M 10-Q · filed 2015-08-04 | $61.68M derived: sum of 3 quarters · filed 2017-02-24 | $83.73M derived: sum of 4 quarters · filed 2017-02-24 | ||
| 2015-03-31 | $15.52M 10-K · filed 2017-02-24 | $15.52M 10-Q · filed 2015-05-04 | $38.77M derived: sum of 2 quarters · filed 2017-02-24 | $60.83M derived: sum of 3 quarters · filed 2017-02-24 | $87.11M derived: sum of 4 quarters · filed 2017-02-24 | |||
| 2014-12-31 | $23.25M 10-K · filed 2016-03-10 | $23.25M 10-K · filed 2015-03-13 | $45.31M derived: sum of 2 quarters · filed 2016-03-10 | $71.58M derived: sum of 3 quarters · filed 2016-03-10 | $105.59M 10-K · filed 2017-02-24 | $105.59M 10-K · filed 2015-03-13 | ||
| 2014-09-30 | $22.05M 10-K · filed 2016-03-10 | $22.06M 10-Q · filed 2014-11-06 | $48.33M derived: sum of 2 quarters · filed 2016-03-10 | $82.34M 10-Q · filed 2015-11-03 | $103.59M derived: sum of 4 quarters · filed 2016-03-10 | |||
| 2014-06-30 | $26.27M 10-K · filed 2016-03-10 | $26.27M 10-Q · filed 2014-08-04 | $60.28M 10-Q · filed 2015-08-04 | $81.54M derived: sum of 3 quarters · filed 2016-03-10 | $99.29M derived: sum of 4 quarters · filed 2016-03-10 | |||
| 2014-03-31 | $34.01M 10-K · filed 2016-03-10 | $34.01M 10-Q · filed 2014-05-05 | $55.26M derived: sum of 2 quarters · filed 2016-03-10 | $73.02M derived: sum of 3 quarters · filed 2016-03-10 | $93.84M derived: sum of 4 quarters · filed 2016-03-10 | |||
| 2013-12-31 | $21.25M 10-K · filed 2015-03-13 | $39.01M derived: sum of 2 quarters · filed 2015-03-13 | $59.83M derived: sum of 3 quarters · filed 2015-03-13 | $75.08M 10-K · filed 2016-03-10 | $75.08M 10-K · filed 2014-03-13 | |||
| 2013-09-30 | $17.75M 10-K · filed 2015-03-13 | $38.58M derived: sum of 2 quarters · filed 2015-03-13 | $53.83M 10-Q · filed 2014-11-06 | $76.44M derived: sum of 4 quarters · filed 2015-03-13 | ||||
| 2013-06-30 | $20.83M 10-K · filed 2015-03-13 | $36.08M 10-Q · filed 2014-08-04 | $58.68M derived: sum of 3 quarters · filed 2015-03-13 | $73.45M derived: sum of 4 quarters · filed 2015-03-13 | ||||
| 2013-03-31 | $15.25M 10-K · filed 2015-03-13 | $37.85M derived: sum of 2 quarters · filed 2015-03-13 | $52.62M derived: sum of 3 quarters · filed 2015-03-13 | $72.24M derived: sum of 4 quarters · filed 2015-03-13 | ||||
| 2012-12-31 | $22.61M 10-K · filed 2014-03-13 | $37.37M derived: sum of 2 quarters · filed 2014-03-13 | $57.00M derived: sum of 3 quarters · filed 2014-03-13 | $71.36M 10-K · filed 2015-03-13 | ||||
| 2012-09-30 | $14.77M 10-K · filed 2014-03-13 | $34.39M derived: sum of 2 quarters · filed 2014-03-13 | $48.75M 10-Q · filed 2013-11-05 | $67.20M derived: sum of 4 quarters · filed 2014-03-13 | ||||
| 2012-06-30 | $19.62M 10-K · filed 2014-03-13 | $33.99M 10-Q · filed 2013-08-06 | $52.43M derived: sum of 3 quarters · filed 2014-03-13 | $70.89M derived: sum of 4 quarters · filed 2014-03-13 | ||||
| 2012-03-31 | $14.36M 10-K · filed 2014-03-13 | $32.80M derived: sum of 2 quarters · filed 2014-03-13 | $51.26M derived: sum of 3 quarters · filed 2014-03-13 | $67.40M derived: sum of 4 quarters · filed 2014-03-13 | ||||
| 2011-12-31 | $18.44M 10-K · filed 2013-03-14 | $36.90M derived: sum of 2 quarters · filed 2013-03-14 | $53.04M derived: sum of 3 quarters · filed 2013-03-14 | $64.78M 10-K · filed 2014-03-13 | ||||
| 2011-09-30 | $18.46M 10-K · filed 2013-03-14 | $34.60M derived: sum of 2 quarters · filed 2013-03-14 | $46.33M 10-Q · filed 2012-11-08 | $61.06M derived: sum of 4 quarters · filed 2013-03-14 | ||||
| 2011-06-30 | $16.14M 10-K · filed 2013-03-14 | $27.88M 10-Q · filed 2012-08-07 | $42.60M derived: sum of 3 quarters · filed 2013-03-14 | $56.47M derived: sum of 4 quarters · filed 2013-03-14 | ||||
| 2011-03-31 | $11.74M 10-K · filed 2013-03-14 | $26.46M derived: sum of 2 quarters · filed 2013-03-14 | $40.33M derived: sum of 3 quarters · filed 2013-03-14 | $54.83M derived: sum of 4 quarters · filed 2013-03-14 | ||||
| 2010-12-31 | $14.72M derived: 10-K 12 month − 10-Q 9 month · filed 2013-03-14 | $28.59M derived: sum of 2 quarters · filed 2013-03-14 | $43.09M derived: sum of 3 quarters · filed 2013-03-14 | $55.56M 10-K · filed 2013-03-14 | ||||
| 2010-09-30 | $13.87M 10-Q · filed 2011-11-04 | $28.37M derived: sum of 2 quarters · filed 2011-11-04 | $40.84M 10-Q · filed 2011-11-04 | |||||
| 2010-06-30 | $14.50M 10-Q/A · filed 2011-08-10 | $26.97M 10-Q/A · filed 2011-08-10 | ||||||
| 2009-12-31 | $40.14M 10-K · filed 2012-03-13 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| ORASURE TECHNOLOGIES INC (OSUR) | United States | $0.272B | -6.26 |
| Cytosorbents Corp (CTSO) | United States | $0.274B | -1.29 |
| TriSalus Life Sciences, Inc. (TLSI) | United States | $0.283B | -9.92 |
| InfuSystem Holdings, Inc (INFU) | United States | $0.253B | 22.52 |
| Mobia Medical, Inc. (MOBI) | United States | $0.293B | |
| TREACE MEDICAL CONCEPTS, INC. (TMCI) | United States | $0.297B | -4.32 |
| UTAH MEDICAL PRODUCTS INC (UTMD) | United States | $0.238B | 20.93 |
| PRO DEX INC (PDEX) | United States | $0.234B | 13.64 |
| Embecta Corp. (EMBC) | United States | $0.319B | 2.10 |
| Neuronetics, Inc. (STIM) | United States | $0.216B | -3.25 |